Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 12. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_4401AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAStatistical method16.64+/- 1.4120% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4402AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAStatistical method57.46+/- 8.3750% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4403AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAStatistical method96.31+/- 10.7670% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4404AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5a/carbo-15aNANAStatistical method16.56+/- 2.7820% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4405AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5a/carbo-15aNANAStatistical method52.17+/- 9.6850% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4406AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5a/carbo-15aNANAStatistical method90.13+/- 14.4270% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4416AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (2.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu3% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4417AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu6% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4418AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (7.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu10% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4419AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (2.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu3% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4420AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu15% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4421AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (7.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu25% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639